Gender and ethnic differences in survival in a cohort of HIV positive clients

Ethnicity and Health

Volumn 1, Issue 1, 1996, Pages 77-85

  Bright, Peter E ^a,b   Arnett, Donna K ^a   Blair, Clifford ^a   Bayona, Manuel ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Lee County AIDS Task Force Inc   (United States)

Author keywords

Epidemiology; Ethnicity; HIV infections; Survival analysis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPARATIVE STUDY; CULTURAL FACTOR; ETHNOLOGY; FEMALE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MORTALITY; NEGRO; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICS; SURVIVAL;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CROSS-CULTURAL COMPARISON; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 0030089752     PISSN: 13557858     EISSN: None     Source Type: Journal    
DOI: 10.1080/13557858.1996.9961772     Document Type: Article

References (51)

1. Centers for Disease Control. Minorities hit hard by HIV. CDC HIV/AIDS Prevention Training Bulletin 1993; April: 1.
2. Castro KG. Distribution of acquired immunodeficiency syndrome and other sexually transmitted diseases in racial and ethnic populations, United States. Ann Epidemiol 1993; 3: 181-4.
3. Chu SY, Buehler JW & Berkelman RL. Impact of the human immunodeficiency virus epidemic on mortality in women of reproductive age. JAMA 1990; 264: 225-9.
4. Guinan ME. Black communities' belief in 'AIDS as genocide': a barrier to overcome for HIV prevention. Ann Epidemiol 1992; 2: 193-5.
5. Minkoff HL & DeHovitz JA. Care of women infected with the human immunodeficiency virus JAMA 1991; 266: 2253-8.
6. Hopkins DR. AIDS in minority populations in the United States. Public Health Rep 1987; 102: 677-81.
7. Blaxhult A, Granath F, Lidman K & Giesecke J. The influence of age on the latency period to AIDS in people infected with HIV through blood transfusion. AIDS 1990; 4: 125-9.
8. Darby SC, Rizza CR, Doll R, Spooner RJD & Thakrar B. Incidence of AIDS and excess mortality associated with HIV in hemophiliacs in the UK: report on behalf of the directors of hemophilia centres in the UK. Br Med J 1989; 298: 1064-8.
9. Moss AR, Bacchetti P, Osmond D et al. Seropositivity for HIV and the development of AIDS or AIDS-related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J 1988; 296: 745-50.
10. Fischl MA, Richman DD, Hansen H & Grieco MH. The safety and efficacy of Zidovudine in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Ann Intern Med 1990; 112: 727-37.
11. Johnston MI & Hoth DF. Present status and future prospects for HIV therapies. Science 1993; 260: 1286-93.
12. Volberding PA, Lagakos SW, Koch MA et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic milliliter. N Engl J Med 1990; 322: 941-9.
13. Wormser GP & Horowitz H. In Wormser GP, Ed. AIDS and other manifestations of HIV infection. New York, Raven Press; 1992: 173-200.
14. Friedland GH, Saltzman B, Vileno J et al. Survival differences in patients with AIDS. J Acquir Immune Defic Syndr 1991; 4: 144-53.
15. Pedersen C, Gerstoft J, Tauris P et al. Trends in survival of Danish AIDS patients from 1981 to 1989. AIDS 1990; 4: 1111-6.
16. Schechter MT, Craib KJP, Le TN et al. Susceptibility to AIDS progression appears early in HIV infection. AIDS 1990; 4: 185-90.
17. Grady C. In Flaskerud JH, Unguarski PJ, Eds. HIV/AIDS: a guide to nursing care, 2nd Ed. Philadelphia, PA, WB Saunders Company; 1992: 30-53.
18. Skowron G & Merigan TC. Chemotherapy and chemoprophylaxis. In Kaslow RA, Francis DP, Eds. The Epidemiology of AIDS. New York, Oxford University Press; 1989: 282-308.
19. DesJarlais DC, Friedman SR & Marmor M. Development of AIDS, HIV seroconversion, and potential cofactors for T4 cell loss in a cohort of intravenous drug users. AIDS 1987; 1: 105-11.
20. Galli M, Lazzarin A & Saracco A. Clinical and immunological aspects of HIV infection in drug addicts. Clin Immunol Immunopath 1989; 50: S166-76.
21. Zangerle R, Fuchs D, Reibnegger G, Fritsch P & Wachter H. Markers for disease progression in intravenous drug users infected with HIV-1. AIDS 1991; 5: 985-91.
22. Kaslow RA & Francis DP. The epidemiology of AIDS. New York, Oxford University Press; 1989: 87-116.
23. Van Griensven GJP, DeVroome EMM & DeWolfe F. Risk factors for progression of human immunodeficiency virus (HIV) infection among seroconverted and seropositive homosexual men. Am J Epidemiol 1990; 132: 203-10.
24. Burns DN, Kramer A, Yellin F et al. Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr 1991; 4: 76-83.
25. Tollerud DJ, Clark JW & Brown LM. The effects of cigarette smoking on T-cell subsets: a population based survey of healthy caucasians. Am Rev Resp Dis 1989; 139: 1446-51.
26. Burack JH, Stall RD & Barrett DC. Depression may accelerate HIV disease progression. AIDS Alert 1992; 7: 43-4.
27. Goodkin K, Blaney NT, Feaster D et al. Active coping style is associated with natural killer cell cytotoxicity in asymptomatic HIV-1 seropositive homosexual men. J Psychosom Res 1992; 36: 635-50.
28. Irwin M, Daniels M, Bloom E, Smith TL & Weiner H. Life events, depressive symptoms, and immune function. Am J Psychiatry 1987; 144: 437-41.
29. Kiecolt-Glaser JK, Glaser R, Strain EC et al. Modulation of cellular immunity in medical students. J Behav Med 1980; 9: 5-21.
30. Kiecolt-Glaser JK, Fisher LD, Ogrocki P et al. Marital quality, marital disruption, and immune function. Psychosom Med 1988; 49: 13-34.
31. Ellerbrock TV, Bush TJ, Chamberland ME & Oxtoby MJ. Epidemiology of women and AIDS in the United States, 1981 through 1990. JAMA 1991; 265: 2971-5.
32. Schoenbaum EE & Webber MP. The underrecognition of HIV in women in an inner-city emergency room. Am J Public Health 1993; 83: 363-8.
33. Stein MD, Liebman B & Wachtel TJ. HIV-positive women: reasons why they are tested for HIV and their clinical characteristics on entry in the health care system. J Gen Intern Med 1990; 6: 286-9.
34. Friedman E. The uninsured. JAMA 1991; 265: 2491-5.
35. Gala C, Pergami A, Catalan et al. Factors associated with psychological help-seeking in HIV disease. J Psychosom Res 1992; 36: 667-76.
36. Green J & Amo PS. The 'medicaidization' of AIDS. JAMA 1990; 264: 635-50.
37. Easterbrook PJ, Keruly JC & Creagh-Kirk T. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. JAMA 1991; 266: 2713-8.
38. Smith MD. Zidovudine: does it work for everyone? JAMA 266: 2750-1.
39. Stein MD, Piette J, Mor V et al. Differences in access to Zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Med 1991; 6: 35-40.
40. Karon JM & Berkelman RL. The geographic and ethnic diversity of AIDS incidence trends in homosexual/bisexual men in the United States. J Acquir Immune Defic Syndr 1991; 4: 1179-89.
41. Selik FP, Castro KG & Pappaioanou M. Racial/ethnic differences in the risk of AIDS in the United States. Am J Public Health 1988; 78: 1539-45.
42. Piette JD, Mor V & Fleishman J. Patterns of survival with AIDS in the US. Health Services Res 1991; 26: 75-93.
43. Rothenberg R, Woelfel M, Stoneburner R et al. Survival with the acquired immunodeficiency syndrome. N Engl J Med 1987; 317: 1297-302.
44. Seage GR, Oddleifson S, Carr E et al. Survival with AIDS in Massachusetts, 1979 to 1989. Am J Public Health 1993; 83: 72-8.
45. Baccetti P, Osmond D & Chaisson RE. Survival patterns of the first 500 patients with AIDS in San Francisco. J Inf Dis 1988; 157: 1044-7.
46. Lemp GF, Hirozawa AM, Cohen JB et al. Survival for women and men with AIDS. J Inf Dis 1992; 166: 74-9.
47. Marasca G & McEvoy M. Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom. Br Med J 1986; 292: 1727-9.
48. Whyte BM, Swanson CE & Cooper DA. Survival of patients with acquired immunodeficiency syndrome in Australia. Med J Aust 1989; 150: 358-62.
49. Stevens PE. Who gets care? Access to care as an arena for nursing action. In Kos-Munson BA, Ed. Who Gets Health Care? New York, Springer Publishing Company; 1993: 11-26.
50. Betts VT. A nursing prospective. In Kos-Munson BA, Ed. Who Gets Health Care? New York, Springer Publishing Company; 1993: 33-5.
51. Bonuck KA & Arno PS. What is access and what does it mean for nursing? In Kos-Munson BA, Ed. Who Gets Health Care? New York, Springer Publishing Company; 1993: 37-42.